Alterity Therapeutics Limited (ATHE) Annual Balance Sheets

Annual · GAAP · USD millions
Access ATHE quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Alterity Therapeutics Limited's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Jun 30 2024) (Jun 30 2023) (Jun 30 2022) (Jun 30 2021)
Assets
Cash And Cash Equivalents21.80
Cash & Short-term Investments21.00
Trade & Other Current Receivables (IFRS combined total)2.59
Other Current Assets12.71
Total Current Assets30.15
Equipment/Property/Plant Net0.00
Tax Assets, Noncurrent32.79
Other Assets, Noncurrent0.15
Trade And Other Current Receivables3.94
Other Current Assets8.77
Noncurrent Assets0.16
Total Assets30.25
Liabilities
Accounts Payable1.69
Current Tax Liabilities0.01
Other Liabilities, Current2.64
Taxes Payable0.00
Current Provisions0.58
Total Current Liabilities2.32
Total Long-term Debt0.00
Noncurrent Provisions0.09
NoncurrentLiabilities0.09
Current Lease Liabilities0.07
Total Liabilities2.38
Stockholders' Equity
Other Equity42.40
Common Stockholder's Equity42.40
Total Stockholder's Equity27.87
Liabilities & Stockholder's Equity30.25
4 historic quarters locked

Sign in to unlock the full Alterity Therapeutics Limited balance sheet history.

About Alterity Therapeutics Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-029135

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License